Erasca (ERAS) Cash from Investing Activities (2020 - 2026)

Erasca (ERAS) reported Cash from Investing Activities of -$243.8 million for Q1 2026, down 811.6% on a YoY basis from $34.3 million in Q1 2025, and down 1086.73% quarter-over-quarter from $24.7 million in Q4 2025.

Erasca (ERAS) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Erasca has reported Cash from Investing Activities for 7 years, with the latest figure at -$243.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 811.6% year-over-year to -$243.8 million; the trailing twelve-month figure through Mar 2026 stood at -$177.7 million (down 34.27% YoY), and the FY2025 full-year result was $100.4 million, up 164.12% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$243.8 million, down from $24.7 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $34.3 million in Q1 2025, with the low at -$243.8 million in Q1 2026.
  • Historically, Cash from Investing Activities has averaged -$27.2 million across 5 years, with a median of -$1.8 million in 2022.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 920.18% — and 2024, when it plunged 5561.98%.
  • Erasca's Cash from Investing Activities stood at -$4.9 million in 2022, then surged by 193.38% to $4.5 million in 2023, then soared by 397.62% to $22.6 million in 2024, then gained by 9.26% to $24.7 million in 2025, then slumped by 1086.73% to -$243.8 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$243.8 million (Q1 2026), $24.7 million (Q4 2025), and $25.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Erasca 4.16 Bn 3.92 Bn - -243.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -243.83 Mn
Mar 31, 2026 -243.83 Mn
Dec 31, 2025 24.71 Mn
Dec 31, 2025 24.71 Mn
Sep 30, 2025 25.70 Mn
Sep 30, 2025 25.70 Mn
Jun 30, 2025 15.75 Mn
Jun 30, 2025 15.75 Mn
Mar 31, 2025 34.27 Mn
Mar 31, 2025 34.27 Mn
Dec 31, 2024 22.62 Mn
Dec 31, 2024 22.62 Mn
Sep 30, 2024 -102.60 Mn
Sep 30, 2024 -102.60 Mn
Jun 30, 2024 -86.61 Mn
Jun 30, 2024 -86.61 Mn
Mar 31, 2024 9.97 Mn
Mar 31, 2024 9.97 Mn
Dec 31, 2023 4.55 Mn
Dec 31, 2023 4.55 Mn